drugset / Trial / NCT02716090
Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the non-inferiority of the product Dalap Duo® compared to Epiduo® medicine to treat acne. Half of the participants will receive Dalap Duo®, while the other half will receive Epiduo®.
Timeline
- Start
- —
- Primary completion
- 2015-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Adapalene | Other / unclassified | 0.1 % | Topical |
| Background | Benzoyl Peroxide | Other / unclassified | 2.5 % | Topical |